FDA Drug Application (022430) for LYSTEDA by FERRING PHARMS AS

Back to FDA Applications sponsored by FERRING PHARMS AS

Application Number022430
Product Number001
FormTABLET;ORAL
Dosage650MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLYSTEDA
Active IngredientTRANEXAMIC ACID

Active IngredientCount
List of drugs with Active Ingredient TRANEXAMIC ACID3


Back to FDA Applications sponsored by FERRING PHARMS AS